CIK 0001077183
- Large accelerated filer
NEOGENOMICS INC
Sign in to watch- Ticker
- NEO
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 742897368
- Phone
- +1 239-768-0600
- Business address
- 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-07 | JONES STEVEN C Director | Exercise or conversion · Stock Option (Right to Buy) | −3,017 | 0 | ||
| 2021-01-07 | JONES STEVEN C Director | Exercise or conversion · Stock Option (Right to Buy) | −4,269 | 0 | ||
| 2020-12-14 | Weiss Lawrence Martin Chief Medical Officer | Exercise or conversion | +50,000 | $6.98 | $349K | 61,717 |
| 2020-12-14 | Weiss Lawrence Martin Chief Medical Officer | Exercise or conversion | +20,000 | $7.27 | $145K | 81,717 |
| 2020-12-14 | Weiss Lawrence Martin Chief Medical Officer | Exercise or conversion | +13,333 | $9.22 | $123K | 95,050 |
| 2020-12-14 | Weiss Lawrence Martin Chief Medical Officer | Exercise or conversion | +16,666 | $13.87 | $231K | 111,716 |
| 2020-12-14 | Weiss Lawrence Martin Chief Medical Officer | Exercise or conversion | +9,005 | $19.60 | $176K | 120,721 |
| 2020-12-14 | Weiss Lawrence Martin Chief Medical Officer | Sale | −20,200 | $51.06 | $1.0M | 100,521 |
| 2020-12-14 | Weiss Lawrence Martin Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2020-12-14 | Weiss Lawrence Martin Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2020-12-14 | Weiss Lawrence Martin Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −13,333 | 6,667 | ||
| 2020-12-14 | Weiss Lawrence Martin Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −16,666 | 8,334 | ||
| 2020-12-14 | Weiss Lawrence Martin Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −9,005 | 27,017 | ||
| 2020-12-14 | JONES STEVEN C Director | Sale | −25,000 | $51.67 | $1.3M | 1,000,000 |
| 2020-12-11 | JONES STEVEN C Director | Sale | −25,000 | $50.52 | $1.3M | 1,025,000 |
| 2020-12-11 | BALLIET JENNIFER VP and Chief Culture Officer | Exercise or conversion | +15,000 | $8.03 | $120K | 39,980 |
| 2020-12-11 | BALLIET JENNIFER VP and Chief Culture Officer | Sale | −15,000 | $49.99 | $750K | 24,980 |
| 2020-12-11 | BALLIET JENNIFER VP and Chief Culture Officer | Exercise or conversion · Stock Option (Right to Buy) | −15,000 | 33,334 | ||
| 2020-12-10 | JONES STEVEN C Director | Sale | −20,000 | $50.30 | $1.0M | 1,050,000 |
| 2020-12-07 | JONES STEVEN C Director | Sale | −45,658 | $49.45 | $2.3M | 1,070,000 |
Page 28 of 51 · 1,005 trades